Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant

NCT05670379 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight and Obesity
Type2diabetes

Interventions

COMBINATION_PRODUCT: Exenatide Implant
DRUG: Bydureon BCise (exenatide extended release)
DRUG: Semaglutide, 1.0 mg/mL

Sponsor

Vivani Medical, Inc

Collaborators

[object Object]